科拓生物(300858.SZ)发布前三季度业绩，归母净利润7623.2万元，增长7.08%

Core Viewpoint - The company reported a revenue increase of 22.25% year-on-year for the first three quarters of 2025, indicating strong growth in its financial performance [1] Financial Performance - The company's operating revenue for the first three quarters reached 267 million yuan [1] - Net profit attributable to shareholders was 76.232 million yuan, reflecting a year-on-year growth of 7.08% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 67.078 million yuan, with a year-on-year increase of 9.79% [1] - Basic earnings per share stood at 0.29 yuan [1]